Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Theor Biol ; 388: 85-95, 2016 Jan 07.
Article in English | MEDLINE | ID: mdl-26493361

ABSTRACT

Tuberculosis, which typically presents as a pulmonary disease, has a complex pathology. The primary site of infection, the Ghon focus, recruits immune cells and a granuloma forms. At earlier stages the granuloma is still vascularized, offering the best opportunity for drug treatment. In the more progressive state blood flow is reduced and a distinct caseous structure develops. Effective delivery of drugs to bacilli in the core of the granuloma becomes very difficult. It is perceivable that granuloma cores could create conditions where bacilli persist and develop resistance. In this study we analyze drug delivery to granulomas by means of a nanoparticle delivery system. The model consists of two parts; the overall distribution of the nanoparticles is described by a simple circulatory model and this result is used in the second part, focusing on transport in a capillary lined with macrophages. Nanoparticles enter the macrophages where they are metabolized and the drugs are released. The model reveals significant differences in drug concentrations between the plasma and macrophages. Based on the results of the model, strategies for improved drug delivery are proposed.


Subject(s)
Antitubercular Agents/administration & dosage , Drug Delivery Systems/methods , Models, Theoretical , Nanoparticles/chemistry , Tuberculoma/drug therapy , Algorithms , Animals , Antitubercular Agents/chemistry , Antitubercular Agents/pharmacokinetics , Biological Transport , Host-Pathogen Interactions/drug effects , Humans , Macrophages/drug effects , Macrophages/metabolism , Macrophages/parasitology , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/metabolism , Mycobacterium tuberculosis/physiology , Rifampin/administration & dosage , Rifampin/chemistry , Rifampin/pharmacokinetics , Time Factors , Tuberculoma/metabolism , Tuberculoma/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...